期刊文献+

Cox-2在舌鳞癌细胞Tca8113增殖机制中的作用 被引量:11

The Role of Cox-2 in the Proliferation of Squamous Cells of Human Tongue Cancer(Tca8113)
下载PDF
导出
摘要 目的:观察并探讨Cox-2在舌鳞癌细胞(Tca8113)增殖机制中的作用。方法:通过免疫细胞化学检测Cox-2在Tca8113细胞中的表达;再通过建立裸鼠荷瘤模型及应用Cox-2特异性抑制剂(SC236)进行干预的方法,观察SC236对Tca8113细胞的增殖活性、致瘤性和成瘤速度的影响。结果:在Tca8113细胞中存在Cox-2的表达;将Tca8113细胞接种于裸鼠颈部皮下可成功诱导出组织学形态与人舌鳞癌基本一致、且表达Cox-2的移植瘤。SC236能够显著抑制Tca8113细胞及其诱导的移植瘤的生长(P<0.01),并明显延缓Tca8113细胞的成瘤速度(P<0.05)。结论:Cox-2在Tca8113细胞的增殖过程中可能发挥重要作用;Cox-2特异性抑制剂可显著抑制Tca8113细胞及其诱导的移植瘤的增殖和生长。 Objective: To observe and explore the role of Cox-2 in the cell proliferation of squamous cells of hu- man tongue cancer (Tca8113 cell). Methods: Immuocytochemistry was used to detect the expression of Cox-2 in the Tca8113 cells in vitro. Then, methods of intervention on Tca8113 cells with SC236 (specific inhibitor of Cox-2), and establishment of athymie mouse model bearing cancer, were used to observe the impact of SC236 on the proliferation, oncogenicity, and velocity of tumorigenesis of Tca8113 cell. Results: Cox-2 was confirmed to be ex- pressed in the Tca8113 cells by imuocytoehemistry. By using Tea8113 cell, transplantation tumor, which was es- sentially consistent with the human squamous ceil cancer of tongue histologically and positive to Cox-2, was suc- cessfully adduced. And SC236, exhibited the significant effect of inhibiting the proliferation activity and the velocity of tumorigenesis of Tca8113 cells, and the growth of the developed transplantation tumor adduced from Tca8113 cell. Conclusion: Cox-2 probably played key role in the proliferation of Tca8113 cell. SC236, a specific inhibitor of Cox-2, had the significant effect of inhibiting the proliferation of Tca8113cell and the growth of transplantation tumor adduced from Tca8113 cell.
出处 《口腔医学研究》 CAS CSCD 2012年第5期395-399,共5页 Journal of Oral Science Research
基金 国家自然科学基金资助项目(编号:81060087)
关键词 COX-2 TCA8113细胞 SC236 细胞增殖 移植瘤 Tca8113 cell Cox-2 SC236 Cell proliferation Transplantation tumor
  • 相关文献

参考文献16

  • 1Jatin PS. Cancer of the head and neck (American cancer soci- ety atlas of oncology) [M]. London.. Bc Decker Inc, UK 2001, 1-4.
  • 2Casiglia J, Woo SB. A comprehensive review of oral cancer [J]. GenDent, 2001, 49(1) : 72-82.
  • 3Tshering Vogel DW, Zbaeren P, Thoeny HC. Cancer of the oral cavity and oropharynx [J]. Cancer Imaging, 2010, 10 (16) : 62-72.
  • 4Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2 [J]. Annu Rev Pharmaeol Toxieol, 1998, 38 : 97-120.
  • 5Cao Y, Prescott SM. Many actions of cyclooxygenase-2 in cellular dynamics and in cancer [J]. J Cell Physiol, 2002, 190(3) : 279-86.
  • 6Masferre JL, Leahy KM, Koki AT, et al. Antiangiogenic and Antitumor Activities of Cyclooxygenase- 2 Inhibitors [J]. Cancer Res, 2000, 60 :1306-11.
  • 7Zhang H, Sun XF. Overexpression of cyclooxygenase- 2 correlates with advanced stages of colorectal cancer [J]. Am J Gastroenterol, 2002, 97(4) : 1037-41.
  • 8Kundu N, Yang Q, Dorsey R, et al. Increased cyclooxygen- ase-2 (COX-2) expression and activity in a murine model of metastatic breast cancer [J]. Int J Cancer, 2001, 93(5) 681-6.
  • 9Matsubayashi H, Infante JR, Winter J, et al. Tumor COX- 2 expression and prognosis of patients with resectable pancre- atic cancer [J]. Cancer BiolTher, 2007, 6(10) : 1569-75.
  • 10Okano H, Shinohara H, Miyamoto A, et al. Concomitant overexpression cyclooxygenase-2 in HER-Positive on smad -reduced human gastric carcinoma is associated with a poor patient outcome [J]. Clin Cancer Res, 2004, 10 (20) : 6938 -45.

二级参考文献10

  • 1Petersen C, Petersen S, Milas L et al. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor [J]. Clin Cancer Res, 2000, 6(6):2513-20.
  • 2Breinig M, Schirmacher P, Kern MA. Cyclooxygenase-2(COX-2)-a therapeutic target in liver cancer [J]. Curr Pharm Des, 2007, 13(32): 3305-15.
  • 3Sudbφ J, Ristim(a)ki A, Sondresen JE, et al. Cyclooxygenase -2 (COX-2) expression in high-risk premalignant oral lesions [J]. Oral Oncol, 2003,39(5): 497-505.
  • 4Shamma A, Yamamoto H, Doki Y,et al. Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus [J]. Clin Cancer Res, 2000 ,6(4) : 1229-1238.
  • 5Pandey M, Prakash O, Santhi WS, et al. Overexpression of COX-2 gene in oral cancer is independent of stage of disease and degree of differentiation [J]. Int J Oral Maxillofac Surg,2008. 37(4) : 379-383.
  • 6Holcik M. The IAP proteins [J]. Trends Genitics, 2002, 18(10) : 537538.
  • 7Conway EM. Three differentially expressed surviving cDNA variants encode proteins with distinct antiapoptic functions [J]. Blood, 2000, 95(4) : 1435-1442.
  • 8Bao R, Connolly DL, Murphy M, et al. Activation of cancer specific gene expression by the survivin promoter [J]. J Natal Cancer Inst, 2002, 94(7) : 522528.
  • 9李春艳,高文信,周延民,张茹慧,赵静辉,李秋实,李艳秋.口腔鳞状细胞癌中凋亡蛋白酶活化因子甲基化的研究[J].口腔医学研究,2009,25(3):279-281. 被引量:4
  • 10钱毅,乔文静,马叶华,武岐山,刘国霞,刘琪.人健康和炎性牙槽骨成骨细胞COX-2、PGE2、OPG,RANKL的表达[J].口腔医学研究,2010,26(4):529-533. 被引量:8

共引文献10

同被引文献115

引证文献11

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部